UPDATE 2-Novartis sets sights on return to growth in 2018
April 25, 2017 at 05:20 AM EDT
* Advances MS drug BAF312 filing date to 2018 from 2019 (Recasts to focus on growth outlook in 2018, adds analyst comments, details)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.